-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Moderator Introduction

Scientific Workshop on Understanding and Overcoming Tumor-intrinsic Resistance to CAR-T Therapies for Lymphoid Malignancies
Program: Scientific Workshops
Session: CAR-19 Resistance in Acute Lymphoblastic Leukemia
Friday, December 6, 2024, 4:18 PM-4:54 PM

Ash A. Alizadeh, MD, PhD

Stanford University, San Mateo, CA

Disclosures: Alizadeh: BMS: Research Funding; Pharmacyclics: Consultancy; Forty Seven: Other: stock; Roche: Consultancy; Gilead: Consultancy; Foresight: Consultancy, Other: Scientific Co-founder; CiberMed: Consultancy, Other: Scientific Co-founder; CARGO Therapeutics: Divested equity in a private or publicly-traded company in the past 24 months; ADC Therapeutics: Consultancy; Adaptive Biosciences: Consultancy.

Previous Presentation | Next Presentation >>